Antifungals represent a critical class of medications designed to combat fungal infections, offering relief from ailments caused by a diverse array of fungi. Azoles, such as fluconazole, interfere with fungal cell membrane synthesis, disrupting their structural integrity and impeding growth. Polyenes, like amphotericin B, bind to fungal cell membranes, causing membrane leakage and eventual cell death. Echinocandins, a newer class, inhibit the synthesis of fungal cell walls, curbing the progression of invasive fungal infections. Antifungals find applications in treating common conditions like athlete's foot and yeast infections, as well as more severe systemic infections such as candidiasis and aspergillosis. However, challenges persist, including the emergence of antifungal resistance, particularly in immunocompromised individuals. Ongoing research strives to unravel new antifungal targets and develop innovative strategies to address the dynamic landscape of fungal infections.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France